OBJECTIVES: We have recently shown that pre-operative thrombocytosis is associated with significantly shorter survival in patients with glioblastoma (GBM). The interaction between platelets and growth of GBM is not clear yet. One hypothesis suggests that platelet-released growth factors support growth and migration of malignant glioma and endothelial cells and thus may increase angiogenesis in these tumors. Another hypothesis would be that larger tumors are associated with poorer survival and produce more factors inducing thrombocytosis. In this study we investigate whether GBM growth induces thrombocytosis. PATIENTS AND METHODS: We compared pre-operative platelet counts of 24 patients with GBM with platelet counts taken 46.3+/-29.2 months (mean+/-1S.D.) prior to diagnosis of GBM. RESULTS: We found immediate pre-operative platelet counts to be significantly higher than the older platelet counts (p=0.02). Furthermore, patients with GBM at time of diagnosis presented with increased platelet counts (314+/-86 platelets/nl) compared to the normal population. CONCLUSION: Our results suggest that elevation of platelet counts in glioblastoma patients is caused by growth and development of GBM. Whether tumor secreted cytokines are the underlying mechanism for this finding, remains to be elucidated.
OBJECTIVES: We have recently shown that pre-operative thrombocytosis is associated with significantly shorter survival in patients with glioblastoma (GBM). The interaction between platelets and growth of GBM is not clear yet. One hypothesis suggests that platelet-released growth factors support growth and migration of malignant glioma and endothelial cells and thus may increase angiogenesis in these tumors. Another hypothesis would be that larger tumors are associated with poorer survival and produce more factors inducing thrombocytosis. In this study we investigate whether GBM growth induces thrombocytosis. PATIENTS AND METHODS: We compared pre-operative platelet counts of 24 patients with GBM with platelet counts taken 46.3+/-29.2 months (mean+/-1S.D.) prior to diagnosis of GBM. RESULTS: We found immediate pre-operative platelet counts to be significantly higher than the older platelet counts (p=0.02). Furthermore, patients with GBM at time of diagnosis presented with increased platelet counts (314+/-86 platelets/nl) compared to the normal population. CONCLUSION: Our results suggest that elevation of platelet counts in glioblastomapatients is caused by growth and development of GBM. Whether tumor secreted cytokines are the underlying mechanism for this finding, remains to be elucidated.
Authors: Matt Williams; Zi Wei Liu; David Woolf; Sarah Hargreaves; Vasiliki Michalarea; Rebecca Menashy; Ishminder Kooner; Elena Wilson Journal: J Cancer Res Clin Oncol Date: 2012-05-27 Impact factor: 4.553
Authors: Pawel Jarmuzek; Marcin Kot; Piotr Defort; Jakub Stawicki; Julia Komorzycka; Karol Nowak; Anna Tylutka; Agnieszka Zembron-Lacny Journal: J Clin Med Date: 2022-06-13 Impact factor: 4.964
Authors: Daniel Kreatsoulas; Chelsea Bolyard; Bill X Wu; Hakan Cam; Pierre Giglio; Zihai Li Journal: J Hematol Oncol Date: 2022-06-11 Impact factor: 23.168
Authors: Nik Sol; Sjors G J G In 't Veld; Adrienne Vancura; Maud Tjerkstra; Cyra Leurs; François Rustenburg; Pepijn Schellen; Heleen Verschueren; Edward Post; Kenn Zwaan; Jip Ramaker; Laurine E Wedekind; Jihane Tannous; Bauke Ylstra; Joep Killestein; Farrah Mateen; Sander Idema; Philip C de Witt Hamer; Anna C Navis; William P J Leenders; Ann Hoeben; Bastiaan Moraal; David P Noske; W Peter Vandertop; R Jonas A Nilsson; Bakhos A Tannous; Pieter Wesseling; Jaap C Reijneveld; Myron G Best; Thomas Wurdinger Journal: Cell Rep Med Date: 2020-10-20
Authors: Keeratikarn Boonyawan; Kenneth R Hess; Jie Yang; Lihong Long; Qianghu Wang; Ravesanker Ezhilarasan; Alessandra Auia; Kristin D Alfaro-Munoz; John F de Groot; Krishna P Bhat; Erik P Sulman Journal: Oncotarget Date: 2017-10-12
Authors: Sascha Marx; Maximilian Splittstöhser; Frederik Kinnen; Eileen Moritz; Christy Joseph; Sebastian Paul; Heiko Paland; Carolin Seifert; Madlen Marx; Andreas Böhm; Edzard Schwedhelm; Kerstin Holzer; Stephan Singer; Christoph A Ritter; Sandra Bien-Möller; Henry W S Schroeder; Bernhard H Rauch Journal: Oncotarget Date: 2018-05-25